Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

The Global Regulatory Cyclic AMP Receptor Protein (CRP) Controls Multifactorial Fluoroquinolone Susceptibility in Salmonella enterica Serovar Typhimurium.

Kary SC, Yoneda JRK, Olshefsky SC, Stewart LA, West SB, Cameron ADS.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01666-17. doi: 10.1128/AAC.01666-17. Print 2017 Nov.

2.

Staphylococcus aureus infections in kidney transplantation: a matched case controlled study.

Florescu DF, Qiu F, West SB, Richards S, Florescu MC, Stevens B, Hill L, Kalil AC.

Scand J Infect Dis. 2012 Jun;44(6):427-32. doi: 10.3109/00365548.2011.652160. Epub 2012 Jan 21.

PMID:
22263696
3.

Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.

Evans LM, Itri LM, Campion M, Wyler-Plaut R, Krown SE, Groopman JE, Goldsweig H, Volberding PA, West SB, Mitsuyasu RT, et al.

J Immunother (1991). 1991 Feb;10(1):39-50.

PMID:
1826454
4.

Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitro.

Miwa GT, West SB, Walsh JS, Wolf FJ, Lu AY.

Chem Biol Interact. 1982 Sep;41(3):297-312.

PMID:
6809347
5.
6.

Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation.

West SB, Wislocki PG, Fiorentini KM, Alvaro R, Wolf FJ, Lu AY.

Chem Biol Interact. 1982 Sep;41(3):265-79.

PMID:
6809345
7.
8.

Kinetic isotope effects in cytochrome P-450-catalyzed oxidation reactions. II. Interactions of cytochrome P-450 with substrates and NADPH-cytochrome C reductase.

Lu AY, Miwa GT, West SB, Hodshon BJ, Garland WA.

Adv Exp Med Biol. 1980;132:95-108. No abstract available.

PMID:
6775516
9.

Multiplicity of mammalian microsomal cytochromes P-45.

Lu AY, West SB.

Pharmacol Rev. 1979 Dec;31(4):277-95. Review. No abstract available.

PMID:
399809
10.
11.

A simple and rapid procedure for the purification of phenobarbital-inducible cytochrome P-450 from rat liver microsomes.

West SB, Huang MT, Miwa GT, Lu AY.

Arch Biochem Biophys. 1979 Mar;193(1):42-50. No abstract available.

PMID:
453857
13.

Structural requirements for the metabolic activation of benzo[a]pyrene to mutagenic products: effects of modifications in the 4,5-, 7,8-, and 9,10-positions.

Wood AW, Levin W, Lu AY, Ryan D, West SB, Yagi H, Mah HD, Jerina DM, Conney AH.

Mol Pharmacol. 1977 Nov;13(6):1116-25. No abstract available.

PMID:
339055
14.

Accessibility of cytochrome P450 in microsomal membranes: inhibition of metabolism by antibodies to cytochrome P450.

Thomas PE, Lu AY, West SB, Ryan D, Miwa GT, Levin W.

Mol Pharmacol. 1977 Sep;13(5):819-31. No abstract available.

PMID:
895718
15.

Liver microsomal electron transport systems. Properties of a reconstituted, NADH-mediated benzo[a]pyrene hydroxylation system.

West SB, Lu AY.

Arch Biochem Biophys. 1977 Aug;182(2):369-78. No abstract available.

PMID:
197888
16.

Liver microsomal DT diaphorase: noninvolvement in hydroxylation of benzo(a)pyrene.

Huang MT, West SB, Lu AY.

Biochem Biophys Res Commun. 1977 Feb 21;74(4):1355-61. No abstract available.

PMID:
402917
17.

Mutagenicity of metabolically activated benzo[a]anthracene 3,4-dihydrodiol: evidence for bay region activation of carcinogenic polycyclic hydrocarbons.

Wood AW, Levin W, Lu AY, Ryan D, West SB, Lehr RE, Schaefer-Ridder M, Jerina DM, Conney AH.

Biochem Biophys Res Commun. 1976 Sep 20;72(2):680-6. No abstract available.

PMID:
791280
18.

Immunochemical evidence for six forms of rat liver cytochrome P450 obtained using antibodies against purified rat liver cytochromes P450 and P448.

Thomas PE, Lu AY, Ryan D, West SB, Kawalek J, Levin W.

Mol Pharmacol. 1976 Sep;12(5):746-58. No abstract available.

PMID:
825720
20.

Multiple forms of rat liver cytochrome P-450. Immunochemical evidence with antibody against cytochrome P-448.

Thomas PE, Lu AY, Ryan D, West SB, Kawalek J, Levin W.

J Biol Chem. 1976 Mar 10;251(5):1385-91.

21.

Multiplicity of liver microsomal cytochrome P-450: separation, purification and characterization.

Lu AY, Ryan D, Kawalek J, Thomas P, West SB, Huang MT, Levin W.

Biochem Soc Trans. 1976;4(1):169-72. No abstract available.

PMID:
1001627
22.

Highly purified cytochrome P-448 and P=450 from rat liver microsomes.

Ryan D, Lu YH, Kawalek J, West SB, Levin L.

Biochem Biophys Res Commun. 1975 Jun 16;64(4):1134-41. No abstract available.

PMID:
1137591
23.

Role of cytochrome b5 in NADPH-and NADH-dependent hydroxylation by the reconstituted cytochrome P-450- or P-448-containing system.

Lu AY, Levin W, West SB, Vore M, Ryan D, Kuntzman R, Conney AH.

Adv Exp Med Biol. 1975;58(00):447-66. No abstract available.

PMID:
239545
24.

Role of cytochrome b5 in hydroxylation by a reconstituted cytochrome P-450-containing system.

Lu AY, West SB, Vore M, Ryan D, Levin W.

J Biol Chem. 1974 Nov 10;249(21):6701-9. No abstract available.

25.
27.

Characterization of partially purified cytochromes P-450 and P-448 from rat liver microsomes.

Lu AY, West SB, Ryan D, Levin W.

Drug Metab Dispos. 1973 Jan-Feb;1(1):29-39. No abstract available.

PMID:
4149398
29.

Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. IV. Hydroxylation of aniline.

Lu AY, Jacobson M, Levin W, West SB, Kuntzman R.

Arch Biochem Biophys. 1972 Nov;153(1):294-7. No abstract available.

PMID:
4650613
31.

The preparation and evaluation of tritiated polyalanyl insulin derivatives.

Canfield RE, Kaye GI, West SB.

Endocrinology. 1972 Jan;90(1):112-22. No abstract available.

PMID:
5009052

Supplemental Content

Support Center